Mitigating the impact of disasters and emergencies on clinical trials site conduct: A site perspective following major and minor unforeseen events
Internationally, the frequency of emergencies and disasters affecting the built environment is increasing. Clinical trials sites that experience an event that affects their clinical trials research infrastructure and site functionality, may find their ability to follow optimal clinical trials conduc...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-12-01
|
Series: | Contemporary Clinical Trials Communications |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451865419302492 |
id |
doaj-95e19bc74aa146a58d4d5fd22c1ee50a |
---|---|
record_format |
Article |
spelling |
doaj-95e19bc74aa146a58d4d5fd22c1ee50a2020-11-25T02:39:48ZengElsevierContemporary Clinical Trials Communications2451-86542019-12-0116Mitigating the impact of disasters and emergencies on clinical trials site conduct: A site perspective following major and minor unforeseen eventsHelen Lunt0Helen Heenan1Corresponding author. Diabetes Outpatients, Canterbury District Health Board, 2 Oxford Terrace, Christchurch Central, Christchurch, 8011, New Zealand.; Diabetes Outpatients, Canterbury District Health Board, Christchurch, New ZealandDiabetes Outpatients, Canterbury District Health Board, Christchurch, New ZealandInternationally, the frequency of emergencies and disasters affecting the built environment is increasing. Clinical trials sites that experience an event that affects their clinical trials research infrastructure and site functionality, may find their ability to follow optimal clinical trials conduct is compromised. There is however minimal published information on how clinical trials sites should best undertake emergency planning and develop resilience. We provide a description (case study) from a site perspective of two unforeseen events, one major and one minor, and discuss ‘lessons learnt’.International collation of post-event information about what worked and what did not, collected across a spectrum of disasters and emergencies affecting facilities undertaking clinical trials, would provide a repository of shared knowledge and help inform the development of strategies aimed at enhancing the resilience of clinical trials sites to extreme events. Keywords: Disaster risk reduction, Emergency planning, Clinical trials, Clinical researchhttp://www.sciencedirect.com/science/article/pii/S2451865419302492 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Helen Lunt Helen Heenan |
spellingShingle |
Helen Lunt Helen Heenan Mitigating the impact of disasters and emergencies on clinical trials site conduct: A site perspective following major and minor unforeseen events Contemporary Clinical Trials Communications |
author_facet |
Helen Lunt Helen Heenan |
author_sort |
Helen Lunt |
title |
Mitigating the impact of disasters and emergencies on clinical trials site conduct: A site perspective following major and minor unforeseen events |
title_short |
Mitigating the impact of disasters and emergencies on clinical trials site conduct: A site perspective following major and minor unforeseen events |
title_full |
Mitigating the impact of disasters and emergencies on clinical trials site conduct: A site perspective following major and minor unforeseen events |
title_fullStr |
Mitigating the impact of disasters and emergencies on clinical trials site conduct: A site perspective following major and minor unforeseen events |
title_full_unstemmed |
Mitigating the impact of disasters and emergencies on clinical trials site conduct: A site perspective following major and minor unforeseen events |
title_sort |
mitigating the impact of disasters and emergencies on clinical trials site conduct: a site perspective following major and minor unforeseen events |
publisher |
Elsevier |
series |
Contemporary Clinical Trials Communications |
issn |
2451-8654 |
publishDate |
2019-12-01 |
description |
Internationally, the frequency of emergencies and disasters affecting the built environment is increasing. Clinical trials sites that experience an event that affects their clinical trials research infrastructure and site functionality, may find their ability to follow optimal clinical trials conduct is compromised. There is however minimal published information on how clinical trials sites should best undertake emergency planning and develop resilience. We provide a description (case study) from a site perspective of two unforeseen events, one major and one minor, and discuss ‘lessons learnt’.International collation of post-event information about what worked and what did not, collected across a spectrum of disasters and emergencies affecting facilities undertaking clinical trials, would provide a repository of shared knowledge and help inform the development of strategies aimed at enhancing the resilience of clinical trials sites to extreme events. Keywords: Disaster risk reduction, Emergency planning, Clinical trials, Clinical research |
url |
http://www.sciencedirect.com/science/article/pii/S2451865419302492 |
work_keys_str_mv |
AT helenlunt mitigatingtheimpactofdisastersandemergenciesonclinicaltrialssiteconductasiteperspectivefollowingmajorandminorunforeseenevents AT helenheenan mitigatingtheimpactofdisastersandemergenciesonclinicaltrialssiteconductasiteperspectivefollowingmajorandminorunforeseenevents |
_version_ |
1724784634763411456 |